�鶹ԭ��

1. Executive Summary
2. Research Methodology
3. Peripheral Vascular Disease
3.1 Overview
3.2 Types of PVD
3.2.1 Functional PVD
3.2.2 Organic PVD
3.4 Diagnosis of PVD
3.5 Treatment of PVD
4. �鶹ԭ�� Analysis
4.1 �鶹ԭ�� Sizing (Actual & Forecasted)
4.2 �鶹ԭ�� Share Analysis
4.2.1 �鶹ԭ�� Share by Devices
4.2.2 �鶹ԭ�� Share by Drugs
4.2.3 �鶹ԭ�� Share by Type of Disease
4.2.4 �鶹ԭ�� Share by Region
5. Country Analysis
5.1 The US
5.1.1 �鶹ԭ�� Sizing (Actual & Forecasted)
5.1.2 �鶹ԭ�� Share by Procedure
5.1.3 �鶹ԭ�� Share by Device
5.2 China
5.2.1 �鶹ԭ�� Sizing (Actual & Forecasted)
5.3 Japan
5.3.1 �鶹ԭ�� Sizing (Actual & Forecasted)
6. �鶹ԭ�� Segmentation
6.1 Peripheral Vascular Stent
6.1.1 Overview
6.1.2 �鶹ԭ�� Sizing (Actual & Forecasted)
6.1.3 �鶹ԭ�� Share by Segment
6.1.4 �鶹ԭ�� Share by Region
6.2 Drug-Coated Balloon (DCB)
6.2.1 Overview
6.2.2 �鶹ԭ�� Sizing (Actual & Forecasted)
6.3 Atherectomy Devices
6.3.1 Overview
6.3.2 �鶹ԭ�� Sizing (Actual & Forecasted)
6.4 Drug Eluting Stent (DES)
6.4.1 Overview
6.4.2 �鶹ԭ�� Sizing (Actual & Forecasted)
6.5 PTA Balloon Catheter
6.5.1 Overview
6.5.2 �鶹ԭ�� Sizing (Actual & Forecasted)
7. Pricing Analysis
8. �鶹ԭ�� Dynamics
8.1 Industry Trends & Development
8.1.1 Precision Vascular Robotics
8.1.2 Advent of Bioresorbable stent
8.1.3 Novel ‘3-D’ Stent System
8.1.4 Specialty Stents for PAD
8.1.5 Other New Technologies
8.2 Growth Drivers
8.2.1 Growing Geriatric Population
8.2.2 High Restenosis Rates
8.2.3 Rising Incidences of PAD
8.2.4 Increasing Public Awareness
8.3 Challenges
8.3.1 Strict Regulatory Compliance
8.3.2 High Cost of Treatment
8.3.3 Others
9. Competitive Landscape
9.1 Product Portfolio
9.1.1 �鶹ԭ�� Share by Competitors
10. Company Profiles
10.1 Boston Scientific
10.2 Medtronic plc
10.3 Abbott Laboratories
10.4 C.R. Bard

List of Tables
Table 1: Symptoms of PVD
Table 2: Tests for Diagnosis of PVD
Table 3: Global Peripheral Intervention Products Pricing Analysis
Table 4: Peripheral Intervention Devices – Self-expanding Stents Pricing Analysis (US$)
Table 5: Peripheral Intervention Devices – Balloon-expandable Stents Pricing Analysis (US$)
Table 6: Peripheral Intervention Devices – Carotid Stents Pricing Analysis (US$)
Table 7: Peripheral Intervention Devices – Covered Endoprostheses Stents Pricing Analysis (US$)
Table 8: Peripheral Intervention Devices – Drug-eluting Stents Pricing Analysis (US$)
Table 9: Peripheral Intervention Devices – PTA Balloon Catheters Pricing Analysis (US$)
Table 10: Peripheral Intervention Devices – Drug-coated Balloons Pricing Analysis (US$)
Table 11: Global Peripheral Vascular Devices �鶹ԭ�� Players Competitive Landscape
Table 12: Recent FDA Approvals of Peripheral Vascular Products Landscape by Companies
Table 13: Drug-coated Balloon Dilatation Catheters Products Landscape by Companies
Table 14: Comparison of Atherectomy Devices by Leading �鶹ԭ�� Players
Table 15: Drug-Coated Balloon (DCB) Under Development by Leading �鶹ԭ�� Players

List of Figures
Figure 1: Rockville Research – Research Methodology
Figure 2: Global Peripheral Vascular Diseases Breakdown by Risk Factors (2017)
Figure 3: Global Peripheral Vascular Disease �鶹ԭ�� Size by Value, 2014-22E (US$ Millions)
Figure 4: Peripheral Vascular Disease Annual Mortality Rate (per 100,000 people) by Nations (2016)
Figure 5: Global Peripheral Vascular Diseases �鶹ԭ�� Share by Devices (2017)
Figure 6: Global Peripheral Vascular Diseases �鶹ԭ�� Share by Drugs (2017)
Figure 7: Global Peripheral Vascular Diseases �鶹ԭ�� Share by Devices (2017)
Figure 8: Global Peripheral Artery Disease �鶹ԭ�� Share by Region (2017)
Figure 9: The US Peripheral Vascular Diseases �鶹ԭ�� Size by Value, 2014-22E (US$ Millions)
Figure 10: The US Peripheral Vascular Disease Intervention �鶹ԭ�� Share by Procedure (2017)
Figure 11: The US Peripheral Vascular Disease Intervention �鶹ԭ�� Share by Device (2017)
Figure 12: China Peripheral Vascular Diseases �鶹ԭ�� Size by Value, 2016-22E (US$ Millions)
Figure 13: China Peripheral Vascular Diseases �鶹ԭ�� Size by Volume, 2010-17 (Millions)
Figure 14: Japan Peripheral Vascular Diseases �鶹ԭ�� Size by Value, 2016-22E (US$ Millions)
Figure 15: Global Peripheral Stent �鶹ԭ�� Size by Value, 2010-22E (US$ Billions)
Figure 16: Global Peripheral Stent �鶹ԭ�� Share by Segment, 2014-22 (%)
Figure 17: Global Peripheral Stent �鶹ԭ�� Share by Region (2017)
Figure 18: Global Drug-Coated Balloon �鶹ԭ�� Size by Value, 2010-22E (US$ Millions)
Excimer Laser Atherectomy
Orbital Atherectomy
Figure 19: Global Atherectomy Devices �鶹ԭ�� Size by Value, 2010-22E (US$ Millions)
Figure 20: Global Drug Eluting Stent (DES) �鶹ԭ�� Size by Value, 2010-22E (US$ Millions)
Figure 21: Global PTA Balloon Catheter �鶹ԭ�� Size by Value, 2010-22E (US$ Millions)
Figure 22: Global Ageing Population (60 and above), 2010-17 (Millions)
Figure 23: Global Peripheral Vascular Diseases Prevalence by Age Group & Gender (2016)
Figure 24: Global Peripheral Artery Diseases Incidence by Region, 2010-16 (Millions)
Figure 25: Global Peripheral Vascular Diseases �鶹ԭ�� Share by Competitors (2017)
Figure 26: Global DEB Treatment in Lower Extremity �鶹ԭ�� Share by Competitors (2017)
Figure 27: Boston Scientific Revenue by Business Segment (FY2017)
Figure 28: Boston Scientific Revenue, FY2012-FY2017 (US$ Billions)
Figure 29: Medtronic plc Revenue by Business Segment (FY2017)
Figure 30: Medtronic plc Revenue, FY2012-FY2017 (US$ Billions)
Figure 31: Abbott Laboratories Revenue by Business Segment (FY2017)
Figure 32: Abbott Laboratories Revenue, FY2012-FY2017 (US$ Billions)
Figure 33: C.R. Bard Revenue by Business Segment (FY2017)
Figure 34: C.R. Bard Revenue, FY2012-FY2017 (US$ Billions)